| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis MJL Peters, DPM Symmons, D McCarey, BAC Dijkmans, P Nicola, ... Annals of the rheumatic diseases 69 (2), 325-331, 2010 | 2005 | 2010 |
| EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update R Agca, SC Heslinga, S Rollefstad, M Heslinga, IB McInnes, MJL Peters, ... Annals of the rheumatic diseases 76 (1), 17-28, 2017 | 1413 | 2017 |
| Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment E Choy, K Ganeshalingam, AG Semb, Z Szekanecz, M Nurmohamed Rheumatology 53 (12), 2143-2154, 2014 | 380 | 2014 |
| Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis EEA Arts, C Popa, AA Den Broeder, AG Semb, T Toms, GD Kitas, ... Annals of the rheumatic diseases 74 (4), 668-674, 2015 | 326 | 2015 |
| Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis CS Crowson, S Rollefstad, E Ikdahl, GD Kitas, PLCM Van Riel, SE Gabriel, ... Annals of the rheumatic diseases 77 (1), 48-54, 2018 | 269 | 2018 |
| Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization WJ Sandberg, A Yndestad, E Øie, C Smith, T Ueland, O Ovchinnikova, ... Arteriosclerosis, thrombosis, and vascular biology 26 (4), 857-863, 2006 | 262 | 2006 |
| Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors T Wæhre, A Yndestad, C Smith, T Haug, SH Tunheim, L Gullestad, ... Circulation 109 (16), 1966-1972, 2004 | 208 | 2004 |
| Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion A Tveit, M Grundtvig, T Gundersen, P Vanberg, AG Semb, E Holt, ... The American journal of cardiology 93 (6), 780-782, 2004 | 202 | 2004 |
| Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study AG Semb, TK Kvien, AH Aastveit, I Jungner, TR Pedersen, G Walldius, ... Annals of the rheumatic diseases 69 (11), 1996-2001, 2010 | 183 | 2010 |
| Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy AG Semb, S van Wissen, T Ueland, T Smilde, T Waehre, MD Tripp, ... Journal of the American College of Cardiology 41 (2), 275-279, 2003 | 164 | 2003 |
| Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis AG Semb, E Ikdahl, G Wibetoe, C Crowson, S Rollefstad Nature Reviews Rheumatology 16 (7), 361-379, 2020 | 162 | 2020 |
| Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms EEA Arts, CD Popa, AA Den Broeder, R Donders, A Sandoo, T Toms, ... Annals of the rheumatic diseases 75 (4), 674-680, 2016 | 152 | 2016 |
| High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients SH Sveaas, A Bilberg, IJ Berg, SA Provan, S Rollefstad, AG Semb, ... British journal of sports medicine 54 (5), 292-297, 2020 | 150 | 2020 |
| Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study SA Provan, AG Semb, J Hisdal, E Stranden, S Agewall, H Dagfinrud, ... Annals of the rheumatic diseases 70 (5), 812-817, 2011 | 150 | 2011 |
| Effect of intensive lipid‐lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease AG Semb, TK Kvien, DA DeMicco, R Fayyad, CC Wun, JC LaRosa, ... Arthritis & Rheumatism 64 (9), 2836-2846, 2012 | 142 | 2012 |
| Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease T Wæhre, JK Damås, L Gullestad, AM Holm, TR Pedersen, KE Arnesen, ... Journal of the American College of Cardiology 41 (9), 1460-1467, 2003 | 142 | 2003 |
| Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use SI Mavrogeni, GD Kitas, T Dimitroulas, PP Sfikakis, P Seo, S Gabriel, ... International journal of cardiology 217, 135-148, 2016 | 139 | 2016 |
| Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries CS Crowson, SE Gabriel, AG Semb, PLCM van Riel, G Karpouzas, ... Rheumatology 56 (7), 1102-1110, 2017 | 128 | 2017 |
| Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study SH Sveaas, IJ Berg, SA Provan, AG Semb, KB Hagen, N Vøllestad, ... PloS one 9 (9), e108688, 2014 | 125 | 2014 |
| Carotid plaque characteristics and disease activity in rheumatoid arthritis AG Semb, S Rollefstad, SA Provan, TK Kvien, E Stranden, IC Olsen, ... The Journal of rheumatology 40 (4), 359-368, 2013 | 124 | 2013 |
